AIM members have different roles in ensuring access to pharmaceuticals
AIM discusses during its general assembly in Rome in November 2017 what could be appropriate steps towards sustainable access to pharmaceuticals. But why should AIM members be involved in those discussions? Are payers not just administrative bodies that do exactly what their governments tell them to do? No! AIM members play different important roles in ensuring that their affiliates have, also in the more distant future, affordable access to the medicines they need. AIM publishes today a paper that describes the different roles in ensuring sustainable access to pharmaceuticals. You find it here.